Kinase blocking inhibition in cancer
This technology introduces novel compositions and methods using mutated forms of TIMP-2 to precisely regulate extracellular MMP-2 activity, offering targeted control over tissue remodeling processes.
Background:
Matrix metalloproteinase-2 (MMP-2) plays a vital role in remodeling the extracellular matrix, which is essential for normal physiological...
Published: 6/16/2026
|
Inventor(s): Dimitra Bourboulia, Mehdi Mollapour, Gennady Bratslavsky
Keywords(s): antibody, extracellular kinase, inhibition, phosphorylation
Category(s): Campus > Upstate Medical University
|
Targeting Protein Phosphatase-5 in Cancer
This technology introduces a novel approach to cancer treatment by targeting Protein Phosphatase 5 (PP5) to regulate apoptosis and inhibit tumor growth, particularly in clear cell renal cell carcinoma (ccRCC).
Background:
Cancer cells often evade programmed cell death, allowing tumors to grow unchecked. In clear cell renal cell carcinoma, dysregulation...
Published: 6/16/2026
|
Inventor(s): Mehdi Mollapour, Gennady Bratslavsky, John Chisholm, Dimitra Bourboulia, Mark Woodford
Keywords(s): cancer, cancer therapy, phosphorylation, Technologies
Category(s): Campus > Upstate Medical University, Technology Classifications > Gene Therapy
|
Targeting Hypoxia-inducible factor 2alpha in cancer
This technology offers a novel approach for new cancer treatments based on inhibiting HIF2α-related processes.
Background:
Hypoxia-inducible factor 2α (HIF2α) transcription factor is involved in the adaptation of cancer cells (including clear cell renal cell carcinoma (ccRCC)) to low oxygen conditions (hypoxia). It plays a role...
Published: 6/15/2026
|
Inventor(s): Mehdi Mollapour, Gennady Bratslavsky, Dimitra Bourboulia, Mark Woodford, John Chisholm
Keywords(s): cancer, cancer therapy, cell proliferation, regulation of transcriptional dynamics, Technologies
Category(s): Campus > Upstate Medical University, Technology Classifications > Therapeutics and Vaccines
|
Small Peptides Targeting Lactate Dehydrogenase-A
This technology presents engineered peptide inhibitors designed to selectively block lactate dehydrogenase A (LDHA) activity, offering a novel therapeutic approach for diseases characterized by elevated LDHA, such as cancer and metabolic disorders.
Background:
Lactate dehydrogenase A (LDHA) is an enzyme that plays a key role in cellular metabolism...
Published: 6/12/2026
|
Inventor(s): Mehdi Mollapour, Gennady Bratslavsky, Mark Woodford
Keywords(s): FLCN, lactate dehydrogenase, metabolic switch, tumor suppressor, Warburg effect
Category(s): Campus > Upstate Medical University
|
Targeting the Folding of Hsp90 Clients by Predicting Their Local Unfolding Status
Computationally predicts potential ideal interaction points for the molecular chaperone heat shock protein-90 (Hsp90).
Background:
Molecular chaperones assist in the folding of unfolded and misfolded polypeptides by stabilization of folding intermediates and prevention of protein misfolding and aggregation. Molecular chaperones are present in all...
Published: 6/12/2026
|
Inventor(s): Mehdi Mollapour, Giorgio Colombo, Mark Woodford, Gennady Bratslavsky, Dimitra Bourboulia
Keywords(s): Technologies
Category(s): Campus > Upstate Medical University, Technology Classifications, Technology Classifications > Biomedical Science and Engineering, Technology Classifications > Healthcare, Technology Classifications > Therapeutics and Vaccines
|